CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 97 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,839,000 | -19.1% | 207,500 | 0.0% | 0.47% | -29.6% |
| Q2 2018 | $4,743,000 | -19.7% | 207,500 | 0.0% | 0.66% | -36.1% |
| Q1 2018 | $5,903,000 | +57.5% | 207,500 | +16.9% | 1.04% | +13.8% |
| Q4 2017 | $3,747,000 | +16.2% | 177,500 | 0.0% | 0.91% | +0.1% |
| Q3 2017 | $3,225,000 | +17.2% | 177,500 | 0.0% | 0.91% | -10.5% |
| Q2 2017 | $2,751,000 | -10.2% | 177,500 | 0.0% | 1.02% | -43.7% |
| Q1 2017 | $3,065,000 | +118.8% | 177,500 | +39.2% | 1.81% | +56.3% |
| Q4 2016 | $1,401,000 | -29.9% | 127,500 | 0.0% | 1.16% | -28.5% |
| Q3 2016 | $1,999,000 | -16.4% | 127,500 | -45.6% | 1.62% | -32.0% |
| Q2 2016 | $2,392,000 | -42.2% | 234,179 | -27.1% | 2.38% | -49.9% |
| Q1 2016 | $4,141,000 | -38.2% | 321,023 | 0.0% | 4.75% | -19.7% |
| Q4 2015 | $6,700,000 | – | 321,023 | – | 5.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |